Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder.

Smith BH, Pelham WE Jr, Gnagy E, Molina B, Evans S.

J Consult Clin Psychol. 2000 Jun;68(3):489-99.

PMID:
10883565
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

4.

[Use of methylphenidate in adults with attention deficit disorder with hyperactivity].

Gauillard J, Castelnau C, Vacheron-Trystram MN, Cheref S, Caroli F.

Encephale. 1997 Jul-Aug;23(4):251-6. Review. French.

PMID:
9417389
6.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
7.

Is attention-deficit hyperactivity disorder in adults a valid disorder?

Spencer T, Biederman J, Wilens T, Faraone SV.

Harv Rev Psychiatry. 1994 Mar-Apr;1(6):326-35. Review.

PMID:
9384867

Supplemental Content

Support Center